Claus R. Lattrich

Landshuter Str. 65
Regensburg, BY 93053, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Resumption of Trastuzumab in Patients With Disease Recurrence After (Neo-) Adjuvant Anti-HER2-therapy in Patients With HER2-positive Breast Cancer.

Resumption of Trastuzumab in Patients With Disease Recurrence After (Neo-) Adjuvant Anti-HER2-therapy in Patients With HER2-positive Breast Cancer.

Journal: Anticancer research

Published: May 26, 2020

Primary metastatic breast cancer in the era of targeted therapy - Prognostic impact and the role of breast tumour surgery.

Primary metastatic breast cancer in the era of targeted therapy - Prognostic impact and the role of breast tumour surgery.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 14, 2017

Polymorphisms in the promoter region of ESR2 gene and susceptibility to ovarian cancer.

Polymorphisms in the promoter region of ESR2 gene and susceptibility to ovarian cancer.

Journal: Gene

Published: March 21, 2014

Effects of estriol on growth, gene expression and estrogen response element activation in human breast cancer cell lines.

Effects of estriol on growth, gene expression and estrogen response element activation in human breast cancer cell lines.

Journal: Maturitas

Published: October 14, 2013

Icb-1 gene polymorphism rs1467465 is associated with susceptibility to ovarian cancer.

Icb-1 gene polymorphism rs1467465 is associated with susceptibility to ovarian cancer.

Journal: Journal of ovarian research

Published: October 08, 2013

Expression of SCUBE2 gene declines in high grade endometrial cancer and associates with expression of steroid hormone receptors and tumor suppressor PTEN.

Expression of SCUBE2 gene declines in high grade endometrial cancer and associates with expression of steroid hormone receptors and tumor suppressor PTEN.

Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

Published: September 24, 2013

G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.

G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.

Journal: Steroids

Published: June 03, 2013

Vaginal Estrogen Therapy for Patients with Breast Cancer.

Vaginal Estrogen Therapy for Patients with Breast Cancer.

Journal: Geburtshilfe und Frauenheilkunde

Published: May 04, 2013

Effects of a combined treatment with tamoxifen and estrogen receptor β agonists on human breast cancer cell lines.

Effects of a combined treatment with tamoxifen and estrogen receptor β agonists on human breast cancer cell lines.

Journal: Archives of gynecology and obstetrics

Published: March 13, 2013

Polymorphisms in the promoter region of estrogen receptor β gene in endometrial cancer.

Polymorphisms in the promoter region of estrogen receptor β gene in endometrial cancer.

Journal: Archives of gynecology and obstetrics

Published: March 10, 2013

icb-1 Gene counteracts growth of ovarian cancer cell lines.

icb-1 Gene counteracts growth of ovarian cancer cell lines.

Journal: Cancer letters

Published: October 24, 2012

Role of estrogen receptor β in gynecological cancer.

Role of estrogen receptor β in gynecological cancer.

Journal: Gynecologic oncology

Published: June 15, 2012

Showing 1-12 of 19

Last Updated: 09/26/2026